Stock listing
GMAB Stock Price, News, Filings & Events — Genmab A/s
Selected listing: GMAB · NASDAQ · USD · US
This page tracks Genmab A/s's GMAB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GMAB:NASDAQ. GMAB:NASDAQ is the stock-level entry point for investors researching Genmab A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. The company has a market capitalization of approximately 17.26 billion USD. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.
- Ticker
- GMAB:NASDAQ
- Asset type
- Stock
- Market cap
- $19.28B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Genmab A/s GMAB:NASDAQ stock context
This page tracks Genmab A/s's GMAB:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GMAB:NASDAQ. GMAB:NASDAQ is the stock-level entry point for investors researching Genmab A/s, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. The company has a market capitalization of approximately 17.26 billion USD. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.
Latest news from Genmab A/s
Notice to Convene an Extraordinary General Meeting of Genmab A/S
September 8, 2026
Genmab A/S : Interim Report for the First Half of 2026
August 6, 2026
Genmab Announces Financial Results for the First Half of 2026
August 6, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
July 15, 2026
Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Tr...
July 6, 2026
Genmab A/s earnings calls
Genmab A/S (GMAB) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Genmab A/S (GMAB) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Genmab A/S (GMAB) Q4 2025 Earnings Call
February 17, 2026 · Replay with transcript and chapters
Genmab A/S (GMAB) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Genmab A/S (GMAB) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Genmab A/S (GMAB) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Genmab A/s
Genmab A/s investor report
Review AI stock analysis and investor report context for GMAB:NASDAQ.
Genmab A/s company profile
View the public company page for Genmab A/s on 6ix.
Genmab A/s news
Read company news and market updates connected to Genmab A/s.
Genmab A/s investor events
Find investor webinars, events, and replay context for Genmab A/s.
Alternate listings
GMAB:OMXCOP
DK · DKK
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GE9:GETTEX
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
0MGB:LSIN
GB · DKK
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GNMSF:OTC
US · USD
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GE9:FWB
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GE9:XETR
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GE9:TRADEGATE
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GMAB:VIE
AT · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
565131:LSX
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GMABC:AQUISEU
GB · DKK
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
565131:LS
DE · EUR
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.
GMABN:BMV
MX · MXN
Alternate listing for Genmab A/s; the primary context on this page is GMAB:NASDAQ.